Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192307 · ClinicalTrials.gov registry record · NA
Effectiveness of Two Water-Based Potassium Oxalate Desensitizers
A NA study of Dentin Sensitivity, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT02192307 is a NA study of Dentin Sensitivity that has completed, run by Procter and Gamble. The registered enrollment target is 60 participants, below the 257-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02192307, a NA study of Dentin Sensitivity, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the safety and effectiveness of two water-based potassium oxalate desensitizers on existing dentinal hypersensitivity.
Conditions Studied
Interventions
- DEVICE Potassium oxalate
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-07 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02192307
The ClinicalTrials.gov registry entry for NCT02192307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 257-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (77% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Potassium oxalate is the first listed.
NCT02192307 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02192307 about?
NCT02192307 is a clinical study titled "Effectiveness of Two Water-Based Potassium Oxalate Desensitizers". This study will compare the safety and effectiveness of two water-based potassium oxalate desensitizers on existing dentinal hypersensitivity.
What is the current status of trial NCT02192307?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-07. Estimated completion is 2014-09.
What conditions does trial NCT02192307 study?
This clinical trial studies the following conditions: Dentin Sensitivity.
What interventions are being tested in trial NCT02192307?
The interventions under investigation include: Potassium oxalate (DEVICE).
Who is sponsoring clinical trial NCT02192307?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02192307 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dentin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief
RECRUITING · NA
-
A Pilot Study to Assess Nominal Versus Controlled Stimuli on Dentinal Hypersensitivity
COMPLETED · NA
-
A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.